Skip to main content
. Author manuscript; available in PMC: 2022 Oct 8.
Published in final edited form as: Nat Methods. 2022 Apr 8;19(6):711–723. doi: 10.1038/s41592-022-01475-6

Extended Data Fig. 3. Assessment of mA calling and LMNB1 targeting.

Extended Data Fig. 3

a, The proportion of all adenines called as methylated at each possible probability mA probability score using two different software packages on ONT reads from two GM12878 DNA samples: untreated genomic DNA and purified genomic DNA methylated by Hia5 in vitro. The untreated DNA provides a measure of the false positive rate (FPR) at each score, since it contains few or no methyl adenines. The Hia-5 treated DNA provides a lower bound on the true positive rate (TPR) at each threshold. b, Estimates of the proportion of As methylated in the Hia5-treated DNA sample at each false discovery rate (FDR) threshold (FDR=FPR/(TPR+FPR), determined from a). At least 80% of the adenines on the Hia5-treated DNA appear to be methylated. c-d, In the DiMeLo-seq workflow, following the primary antibody and pA/G-MTase binding and wash steps, a sample of nuclei can be taken for quality assessment by immunofluorescence. One can determine the locations and relative quantity of pA/G-MTase molecules using fluorophore-conjugated antibodies that bind to the pA/G-MTase but not to the primary antibody. In these representative images, the results for pAG-EcoGII are shown, comparing different antibodies, detergents, and samples with (d) and without (c) the use of an unconjugated secondary antibody to recruit more pA/G-MTase molecules to the target protein. Scale bars representing 10 microns are shown in the FITC channel images as white lines.